![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4294|14|22|2590-2599
ISSN: 1568-0266
Source: Current Topics in Medicinal Chemistry, Vol.14, Iss.22, 2014-11, pp. : 2590-2599
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Genomics and new targets for multiple sclerosis
By Baranzini Sergio E Oksenberg Jorge R
Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novel peptides for the treatment of multiple sclerosis
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novel therapeutic agents for multiple sclerosis
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 12, 1999-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oxidative Stress in Tumor Angiogenesis - Therapeutic Targets
Current Pharmaceutical Design, Vol. 16, Iss. 35, 2010-12 ,pp. :